Escitalopram versus citalopram: the surprising role of the R-enantiomer.
about
Citalopram versus other anti-depressive agents for depressionEffects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the ratChronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compoundIs escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transportersEscitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression.Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysisComparative efficacy of escitalopram in the treatment of major depressive disorder.Escitalopram therapy for major depression and anxiety disorders.Escitalopram treatment of menopausal hot flashes.A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dotsTransfer of escitalopram and its metabolite demethylescitalopram into breastmilkEffects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporterEscitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.Escitalopram in the treatment of obsessive-compulsive disorder.The therapeutic potential of escitalopram in the treatment of panic disorder.Escitalopram for the treatment of major depression and anxiety disorders.A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram.Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach.A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.Chiral determination of antidepressant drugs and their metabolites in biological samples.Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.Clinical pharmacology review of escitalopram for the treatment of depression.Evidence-based treatment of anxiety disorders.Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporterR- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.Antidepressant activity of methanolic extract of amaranthus spinosus.Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.The well of novel antidepressants: running dry.What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders.A validated silver-nanoparticle-enhanced chemiluminescence method for the determination of citalopram in pharmaceutical preparations and human plasma.Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain.Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects.
P2860
Q24202141-D6699821-7BEC-4FF5-9732-FD537420483FQ28571028-A10A56B4-665C-40A8-B1EA-15C29861ADB8Q28583883-106B2F83-A436-4F59-90D5-C29AE9175703Q30493395-2E82BC0C-31F2-4FB5-95D8-BC468CC624B4Q33718185-B24396A9-F2EB-40A1-A888-A468E596EFD4Q34072466-6A2C0AF6-6C5F-4396-972A-EC4A0751FCCAQ34102188-906EB41D-3E06-4C6B-A245-CE698C8886CCQ34180357-2187C332-CFC5-4A2D-AA30-F9C866D65F1DQ34480541-013D18F6-9B7A-4F12-BCE6-5814479D1D35Q34664591-03F8E61F-E518-490A-BA44-704BAC9C6D43Q34685982-AFDAE3E2-08BA-4057-9550-1AB91C583C5FQ35234675-8C9C129E-DE57-4A40-80B2-EE55558DC44AQ35607595-E89A103A-5EAE-4EC9-B124-4936AA69A11CQ35827773-FFB6DFAF-60ED-44AE-B2FA-71E3B496AFCEQ36377605-9CA90337-E26B-4DC5-ADD4-CBAF7A65D6D8Q36407799-14FDE384-B9FE-4C12-98D6-8D725B570FCDQ36479510-43514FED-FF68-4DDF-9704-DDB07EA213DDQ36960563-1773EB73-38F3-4F46-99A5-B653ADE52153Q37111879-C0EE900A-CD91-48C5-B676-3E7DDD2CBD78Q37129822-7A184BB2-E347-4218-8638-5BBAAC336046Q37139768-C458520D-BAFF-4696-90DB-505271D8C1F4Q37224425-C166199E-5BF5-4E89-87C8-F479B8C617EDQ37277586-878154B1-CBB6-4425-91F3-A78FA0BD92EEQ37539807-4A209713-4458-4FE1-9462-C51C6BB3F909Q37623353-21BFC1E2-A46F-4CA6-B6F9-9CC9ECF6B1FBQ37810213-E9060F40-8BF7-4D27-9EB7-9859675276AEQ37928965-C866C3A8-7493-4DE9-8C11-380452890D62Q38167375-4D79D8EF-3ED3-4878-A302-8E66BC230DDEQ38220450-F3153A44-2EB2-4C09-BAC1-5C04E0E812F1Q38572969-983CB939-08DC-47D8-B36A-38115B35E2D8Q40769483-D86A066C-9054-48A0-A696-890B1BC80201Q42041458-AA90C3F9-E44F-4EB2-A0ED-E1425C5F4331Q42129272-ABC9AA69-10A8-42ED-A739-2D9EF25456E6Q42739872-83810CD7-226F-41F4-9079-7A96BC87600EQ42955459-93347399-6E78-4E2F-ABC1-EEA63E360FA8Q43042829-72453F02-AF7D-4501-93AA-C11CB37E9220Q45166992-4E2CEAA0-6601-45FF-AE0B-D7E51902B4A7Q45258420-45DD3388-3770-45C0-AAC0-BEDD101B0BC1Q46775779-974CA9A9-E704-40B1-8108-9B6FE1FE9686Q46807637-B3B9061C-CCC0-4A22-A80E-FA5B390DF08D
P2860
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@ast
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@en
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@nl
type
label
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@ast
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@en
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@nl
prefLabel
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@ast
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@en
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@nl
P2093
P1433
P1476
Escitalopram versus citalopram: the surprising role of the R-enantiomer.
@en
P2093
Bjarke Ebert
Claus Braestrup
Connie Sánchez
Elin Heldbo Reines
Klaus P Bøgesø
P2888
P304
P356
10.1007/S00213-004-1865-Z
P577
2004-07-01T00:00:00Z
P5875
P6179
1038838405